Seleno L-methionine acts on cyclophosphamide-induced kidney toxicity

Biological Trace Element Research

Volumn 136, Issue 2, 2010, Pages 171-179

  Ayhanci, Adnan ^a   Günes, Sibel ^a   Sahinturk, Varol ^a   Appak, Sila ^b   Uyar, Ruhi ^a   Cengiz, Mustafa ^a   Altuner, Yilmaz ^a   Yaman, Suzan ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

Author keywords

Cyclophosphamide; Cytoprotectivity; Kidney; Nephrotoxicity; Rat; Seleno L methionine

Indexed keywords

C 0768; CYCLOPHOSPHAMIDE; GLUTATHIONE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; S 3132; SELENOMETHIONINE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ANTIOXIDANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MECHANISM; FEMALE; INFLAMMATION; KIDNEY DYSFUNCTION; KIDNEY HOMOGENATE; KIDNEY INJURY; MALE; NEPHROTOXICITY; NONHUMAN; PROTEIN DEPLETION; RAT; RENAL PROTECTION; SPRAGUE DAWLEY RAT; TISSUE LEVEL; ANIMAL; BLOOD; DRUG EFFECTS; KIDNEY; PATHOLOGY; STANDARD; TOXICITY;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CYCLOPHOSPHAMIDE; FEMALE; GLUTATHIONE; KIDNEY; MALE; MALONDIALDEHYDE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REFERENCE STANDARDS; SELENOMETHIONINE;

RATTUS;

EID: 77955577352     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12011-009-8535-2     Document Type: Article

References (35)

1. Dollery C (1999) Cyclophosphamide- Therapeutic drugs- Churchill Livingstone, Edinburg, pp 349-353
2. Kopecna L (2001) Late effects of anticancer therapy on kidney function in children with acute lymphoblastic leukemia- Bratisl Lek Listy 102:357-360
3. Okamura T, Garland EM, Taylor RJ, Johansson SL, Cohen SM (1992) The effect of cyclophosphamide administration on the kidney of the rat Toxicol Lett 63:261-276
4. Gustafsson LL, Eriksson L, Dahl S, Eleborg L (1996) Cyclophosphamide induced acute liver failure requiring transplantation in a patient with genetically deficient debrisoquine metabolism: a causal relationship? J Int Med 240:311-314
5. Rossi R, Godde A, Kleinebrand A, Riepenhausen M, Boos J, Ritter J (1994) Unilateral nephrectomy and cisplatin as risk factor of ifosfamide-induced nephrotoxicity: analysis of 120 patients- J Clin Oncol 12:159-165
6. Sugumar E, Kanakasabapathy I, Abraham P (2007) Normal plasma creatinine level despite histological evidence of damage and increased oxidative stress in the kidneys of cyclophosphamide treated rats- Clin Chim Acta 376:244-245
7. Abraham P, Rabi S (2009) Nitrosative stress, protein tyrosine nitration, PARP activation and NAD depletion in the kidneys of rats after single dose of cyclophosphamide- Clin Exp Nephrol 13:281-287- doi:10-1007/s10157-009-0160-z
8. Kern JC, Kehrer JP (2002) Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis- Chem Biol Interact 139:79-95
9. Arumugam N, Sivakumar V, Thanislass J, Devaraj H (1997) Effects of acrolein on rat liver antioxidant defense system- Indian J Exp Biol 35:1373-1374
10. Mythili Y, Sudharsan PT, Selvakumar E, Varalakshmi P (2004) Protective effect of dl-α-lipoic acid on cyclophosphamide induced oxidative cardiac injury- Chem Biol Interact 151:13-19 (Pubitemid 39647933)
11. Kawanishi M, Matsuda T, Nakayama A, Takebe H, Matsui S, Yagi T (1998) Molecular analysis of mutations induced by acrolein in human fibroblast cells using supf shuttle vector plasmids- Mut Res Gen Toxicol Environ Mutagen 417:65-73 (Pubitemid 28414378)
12. Fouladi M, Stempak D, Gammon J (2001) Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin and etoposide chemotherapy in children with refractory carcinoma- Cancer 92:914-923
13. Schrauzer GN (2003) The nutritional significance, metabolism, and toxicology of selenomethionine. Adv Food Nutr Res 47:73-112
14. Flohe L, Gunzler WA, Loschen G (1979) The glutathione peroxidase reaction: a key to understand the selenium requirement of mammals. Trace metals in health and disease. Raven, New York, pp 263-286
15. Bauer G, Wendel A (1980) The activity of the peroxide-metabolizing system in human colon carcinoma. J Cancer Res Clin Oncol 97:267-273
16. Cao S, Durrani FA, Rustum YM (2004) Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin Cancer Res 10:2561-2569
17. Ayhanci A, Uyar R, Aral E, Kabadere S, Appak S (2008) Protective effect ofzinc on cyclophosphamide- induced hematoxicity and urotoxicity. Biol Trace Elem Res 126:186-193
18. Mohan IK, Khan M, Shobha JC, Naidu MU, Prayag A, Kuppusamy P (2006) Protection against cisplatin-induced nephrotoxicity by Spirulina in rats. Cancer Chemother Pharmacol 586:802-808 (Pubitemid 44351261)
19. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
20. Levine LA, Richie JP (1989) Urological complications of cyclophosphamide. J Urol 141:1063-1069
21. Ayhanci A, Yaman S, Sahinturk V, Uyar R, Bayramoglu G, Senturk H, Altuner Y, Appak S, Gunes S (2009) Protective effect of seleno-L-methionine on cyclophosphamide-induced urinary bladder toxicity in rats. Biol Trace Elem Res. doi:10.1007/s 12011-009-8458-y
22. Philips FS, Sternberg SS, Cronin AP, Vidal PM (1961) Cyclophosphamide and urinary bladder toxicity. Cancer Res 21:1577-1589
23. Levine S, Sowinski R (1974) Cyclophosphamide-induced cerebral and visceral lesions in rats. Arch Pathol 98:177-182
24. Hsu HC, Tsai HM (1982) Cyclophosphamide-induced glomerular injury in newborn mice. Lab Invest 47:281-285
25. Senthilkumar S, Devaki T, Manohar BM, Babu MS (2006) Effect of squalene on cyclophosphamide-induced toxicity. Clin Chim Acta 364:335-342
26. Cayir K, Karadeniz A, Yildirim A, Kalkan Y, Karakoc A, Keles M, Tekin SB (2009) Protective effect of L-carnitine against cisplatin-induced liver and kidney oxidant injury in rats. Cent Eur J Med 4(2):184-191
27. Lu Y, Cederbaum A (2007) The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: modulation by ERK, ROS, glutathione, and thioredoxin. Free Radic Biol Med 43:1061-1075
28. Nannelli A, Messina A, Marini S, Trasciatti S, Longo V, Gervasi PG (2007) Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues. Arch Toxicol 81:479-487
29. Whanger PD (1981) Selenium and heavy metal toxicity. In: Spallholz JE, Martin JL, Ganther HE (eds) Selenium in biology and medicine. AVI, Westport, pp 230-255
30. Diplock AT, Watkins WJ, Heurson M (1986) Selenium and heavy metals. Ann Clin Res 18:55-60
31. Ip C (1986) Selenium and experimental cancer. Ann Clin Res 18:22-29
32. Jamba L, Nehru B, Bansal MP (1997) Selenium supplementation during cadmium exposure: changes in antioxidant enzymes and the ultrastructure of the kidney. The Journal of Trace Elements in Experimental Medicine 10:233-242
33. Gray KJ, Engelmann UH, Fishman IJ (1986) Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (cytoxan) therapy. J Urol 133:497-500
34. Furst A (2002) Can nutrition affect chemical toxicity? Int J Toxicol 21:419-424
35. Tripathi DN, Jena GB (2008) Ebselen attenuates cyclophosphamide-induced oxidative stress and DNA damage in mice. Free Radic Res 42(11):966-977